These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 2122309)

  • 1. Workshop on diagnosis and prognosis of HIV infection, Armed Forces Retrovirus Research Group.
    Mil Med; 1990 Jun; 155(6):283-7. PubMed ID: 2122309
    [No Abstract]   [Full Text] [Related]  

  • 2. Insensitivity of a synthetic peptide-based test (Pepti-LAV 1-2) for the diagnosis of HIV infection in African children.
    Brattegaard K; Soroh D; Zadi F; Digbeu H; Vetter KM; De Cock KM
    AIDS; 1995 Jun; 9(6):656-7. PubMed ID: 7662211
    [No Abstract]   [Full Text] [Related]  

  • 3. Diagnosis of HIV infection and laboratory monitoring of its therapy.
    Yilmaz G
    J Clin Virol; 2001 Jun; 21(3):187-96. PubMed ID: 11397655
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Diagnostic tests: Human immunodeficiency virus type 1, type 2 (HIV-1, HIV 2)].
    Fujii T
    Nihon Rinsho; 2005 Jul; 63 Suppl 7():434-7. PubMed ID: 16111295
    [No Abstract]   [Full Text] [Related]  

  • 5. HIV-2 infection and HIV-1/HIV-2 dual reactivity in patients with and without AIDS-related symptoms in Gabon.
    Tevi-Benissan C; Okome M; Makuwa M; Nkoume MN; Lansoud-Soukate J; Georges A; Georges-Courbot MC; Belec L
    Emerg Infect Dis; 1998; 4(1):130-1. PubMed ID: 9452410
    [No Abstract]   [Full Text] [Related]  

  • 6. Acute Epstein-Barr virus infection and human immunodeficiency virus antibody cross-reactivity.
    Ladizinski B; Sankey C
    Am J Med; 2014 Jun; 127(6):e9-10. PubMed ID: 24608015
    [No Abstract]   [Full Text] [Related]  

  • 7. [Modern serologic diagnosis of HIV 1 and HIV 2 infection].
    Mertens T
    Verh Dtsch Ges Inn Med; 1991; 97():375-81. PubMed ID: 1808918
    [No Abstract]   [Full Text] [Related]  

  • 8. New HIV algorithm holds promise.
    Appold K
    MLO Med Lab Obs; 2012 Apr; 44(4):28, 30. PubMed ID: 22586852
    [No Abstract]   [Full Text] [Related]  

  • 9. Virological exploration of individuals with discordant HIV screening tests.
    Pasquier C; Sandres-Sauné K; Mansuy JM; Puissant B; Viraben R; Spenato N; Miédougé M; Massip P; Blancher A; Izopet J
    J Clin Virol; 2004 Jul; 30(3):218-23. PubMed ID: 15135738
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Increasing prevalence of HIV-2 and dual HIV-1-2 infections among patients attending various outdoor patient departments in Mumbai (Bombay).
    Kamat HA; Banker DD; Koppikar GV
    Indian J Public Health; 1999; 43(2):85-6. PubMed ID: 11243075
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The characteristics of screening and confirmatory test results for HIV in Xi'an, China.
    Wang L; Zhou KH; Zhao HP; Wang JH; Zheng HC; Yu Y; Chen W
    PLoS One; 2017; 12(7):e0180071. PubMed ID: 28686629
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cross-sectional study of community serostatus to highlight undiagnosed HIV infections with oral fluid HIV-1/2 rapid test in non-conventional settings.
    Parisi MR; Soldini L; Vidoni G; Clemente F; Mabellini C; Belloni T; Nozza S; Brignolo L; Negri S; Rusconi S; Schlusnus K; Dorigatti F; Lazzarin A
    New Microbiol; 2013 Apr; 36(2):121-32. PubMed ID: 23686118
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification and characterization of sera from HIV-infected individuals with broad cross-neutralizing activity against group M (env clade A-H) and group O primary HIV-1 isolates.
    Beirnaert E; Nyambi P; Willems B; Heyndrickx L; Colebunders R; Janssens W; van der Groen G
    J Med Virol; 2000 Sep; 62(1):14-24. PubMed ID: 10935983
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification of human immunodeficiency virus type 2 in a New Zealand resident.
    Shroeder BA; Bridle M; Croxson MC; Franklin R
    N Z Med J; 1994 Jun; 107(979):217-9. PubMed ID: 8208481
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Towards a better understanding of the epidemiology of HIV-2.
    Schim van der Loeff MF; Aaby P
    AIDS; 1999; 13 Suppl A():S69-84. PubMed ID: 10885765
    [No Abstract]   [Full Text] [Related]  

  • 16. Protective immunity against HIV infection: lessons from HIV-2 infection.
    Rowland-Jones S
    Future Microbiol; 2006 Dec; 1(4):427-33. PubMed ID: 17661633
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Search for antibodies against human immunodeficiency virus type 2 (HIV-2) in a sample of parenteral drug addicts (IVDA)].
    Ortiz de Lejarazu R; Eiros JM; Perlado del Campo E; Palenzuela MS; Reguera JI; Rodríguez-Torres A
    Enferm Infecc Microbiol Clin; 1990 Jan; 8(1):48-51. PubMed ID: 2095905
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Diagnosis of HIV-1/2 dual infection using dilution analysis of type-specific antibody.
    Ariyoshi K; Cham F; Berry N; Harding E; Sabally S; N'Gom PT; Ishikawa K; Corrah T; Tedder R; Whittle H
    AIDS; 1998 Dec; 12(18):2504-5. PubMed ID: 9875593
    [No Abstract]   [Full Text] [Related]  

  • 19. Synthetic peptide assays to detect human immunodeficiency virus types 1 and 2 in seropositive individuals.
    Smith RS; Parks E
    Arch Pathol Lab Med; 1990 Mar; 114(3):254-8. PubMed ID: 2407213
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Detection of HIV infection by serologic procedures].
    Schmidt BL
    Z Hautkr; 1990 Jul; 65(7):633-4, 637-9. PubMed ID: 2205060
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.